Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Norway Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20052
20063
20072
20082
20101
20141
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi6
Boehringer Ingelheim3
Asker & Baerum Hospital2
Bristol-Myers Squibb2
Bayer1
CSL Behring1
Daiichi Sankyo1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Region Stockholm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation18
Stroke6
Atrial Flutter2
Cardiovascular Diseases2
Embolism2
Acute Coronary Syndrome1
Arrhythmias, Cardiac1
Atherosclerosis1
Cerebral Hemorrhage1
Coronary Artery Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.